Do Endurocide® Curtains need Safety Data Sheets?
Our Endurocide® Antimicrobial Plus Curtains are treated with a proprietary and patented coating of biocides, binding agents and flame retardants.
According to European legislation(1) regarding the placement of biocides and products containing biocides on the market, Endurocide® Antimicrobial Plus Curtains are to be regarded as “treated articles”.
Many 'treated articles' go on the market without any form of hazard labelling as the quantities of biocides present are not high enough to be dangerous to the majority of the population
Did you know?
Many pillows, blankets, duvets, socks and underwear are treated with small amounts of biocidal preservatives such as PHMB and similar chemistry. These are applied to manage malodour and bacterial build-up. They can also be considered "treated articles".
In comparison to the above examples, our Endurocide® Antimicrobial Plus Curtains are impregnated with relatively high concentrations of biocides, as they are designed to be effective against pathogens such as spores, bacteria, fungi and mycobacteria.
Typically, safety information for chemicals is communicated to the end-user via Safety Data Sheets (SDS). However, SDS are only considered appropriate for liquids, gases, powders etc.(2)
Under European chemical legislation(3), SDS for "treated articles" are not required, nor considered appropriate. As Endurocide® Antimicrobial Plus Curtains are considered "treated articles" under this legislation, they do not have or require an SDS.
However, as we would do with any product that we manufacture, we have conducted an in-depth analysis on the individual chemical components present in the formula we apply to our Curtains during the manufacturing treatment process. This has been conducted in order to satisfy ourselves as to the safety of the individual component parts used in our formula.
Need more information?
Due to the proprietary nature of our patented treatment formula, specific details regarding our analysis are only available on request. Should you wish to discuss any of the above further, or request information on our findings, please contact us: